Variable | Patients undergoing MTH procedure | Control group | p |
---|---|---|---|
 | (n = 24) | (n = 27) |  |
Coronary artery treated with PCI | Â | Â | ns |
  LM | 0 | 2 | |
  LAD | 16 | 19 | |
  Cx | 8 | 8 | |
  AL | 0 | 1 | |
  RCA | 8 | 12 | |
Number of coronary arteries treated with PCI | Â | Â | ns |
  single-vessel PCI | 17 | 18 | |
  dual-vessel PCI | 6 | 9 | |
  triple-vessel PCI | 1 | 2 | |
Number of lesions treated with PCI | Â | Â | ns |
  single-lesion PCI | 13 | 14 | |
  dual-lesion PCI | 9 | 12 | |
  triple-lesion PCI | 2 | 1 | |
Type of lesion treated with PCI according to the ACC/AHA classification | Â | Â | ns |
  B1 | 11 | 7 | |
  B2 | 11 | 9 | |
  C | 15 | 25 | |
Baseline flow in the culprit artery | Â | Â | ns |
  TIMI 0 or 1 | 15 | 20 | |
  TIMI 2 | 1 | 1 | |
  TIMI 3 | 8 | 7 | |
Final flow in the culprit artery | Â | Â | ns |
  TIMI 0 | 0 | 1 | |
  TIMI 3 | 24 | 26 | |
Number of stents implanted for patient | Â | Â | ns |
  0 | 0 | 2 # | |
  1 | 10 | 12 | |
  2 | 8 | 8 | |
  3 or more | 5 | 5 | |
Type of implanted stent | Â | Â | ns |
  bare metal stent | 42 | 48 | |
  drug-eluting stent | 1 | 0 | |
Total length of implanted stents per patient [mm] | 33 (15–44) | 33 (16–50) | ns |
Diameter of implanted stent [mm] | 3.3 (2.8-3.5) | 3.0 (2.8-3.4) | ns |
Therapy with abciximab | 5 (20.8%) | 5 (18.5%) | ns |
Application of thrombectomy | 6/24 | 3/27 | ns |
Door-to-balloon time * [minutes] | 40.5 (31.5-68.5) | 70.0 (32.0-81.0) | ns |
Direct effect of PCI in the culprit lesion | Â | Â | ns |
  optimal | 23 | 25 | |
  suboptimal | 1 | 1 | |
  ineffective | 0 | 1 |  |